KR20100088251A - 면역활성이 증진된 구멍갈파래 추출물의 제조방법 - Google Patents
면역활성이 증진된 구멍갈파래 추출물의 제조방법Info
- Publication number
- KR20100088251A KR20100088251A KR1020090007332A KR20090007332A KR20100088251A KR 20100088251 A KR20100088251 A KR 20100088251A KR 1020090007332 A KR1020090007332 A KR 1020090007332A KR 20090007332 A KR20090007332 A KR 20090007332A KR 20100088251 A KR20100088251 A KR 20100088251A
- Authority
- KR
- South Korea
- Prior art keywords
- extraction
- high pressure
- activity
- extract
- high temperature
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title abstract description 19
- 241000196259 Ulva pertusa Species 0.000 title abstract description 7
- 230000036039 immunity Effects 0.000 title abstract description 4
- 230000000694 effects Effects 0.000 title description 12
- 230000005965 immune activity Effects 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 235000004347 Perilla Nutrition 0.000 claims description 2
- 244000124853 Perilla frutescens Species 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 8
- 238000004108 freeze drying Methods 0.000 abstract description 5
- 238000001914 filtration Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 238000007789 sealing Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 description 37
- 210000004027 cell Anatomy 0.000 description 19
- 230000008569 process Effects 0.000 description 11
- 241000234282 Allium Species 0.000 description 9
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 9
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 8
- 210000002540 macrophage Anatomy 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000003809 water extraction Methods 0.000 description 7
- 239000002158 endotoxin Substances 0.000 description 6
- 229920006008 lipopolysaccharide Polymers 0.000 description 6
- 210000002421 cell wall Anatomy 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 210000000822 natural killer cell Anatomy 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 150000004804 polysaccharides Chemical class 0.000 description 5
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 description 4
- 229940072113 onion extract Drugs 0.000 description 4
- 241001474374 Blennius Species 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000002429 anti-coagulating effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000021384 green leafy vegetables Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000003308 immunostimulating effect Effects 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 231100000699 Bacterial toxin Toxicity 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 240000007058 Halophila ovalis Species 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- MZNYWPRCVDMOJG-UHFFFAOYSA-N N-(1-naphthyl)ethylenediamine dihydrochloride Chemical compound [Cl-].[Cl-].C1=CC=C2C([NH2+]CC[NH3+])=CC=CC2=C1 MZNYWPRCVDMOJG-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 101150005851 NOS gene Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 241000206607 Porphyra umbilicalis Species 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 241000196252 Ulva Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229920001284 acidic polysaccharide Polymers 0.000 description 1
- 150000004805 acidic polysaccharides Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Sample | High-Pressure(Mpa) | temperature(℃) |
yields
(%, w/w) |
Ulva pertusa kjellman
|
- | 100 | 4.98 |
150 | 50 | 8.31 | |
150 | 110 | 12.28 |
Claims (1)
- 구멍갈파래를 120~150Mpa, 110~120℃의 조건으로 1~5분 동안 추출하는 단계를 포함하는 것을 특징으로 하는 면역 활성이 증진된 구멍갈파래 추출물의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090007332A KR101097799B1 (ko) | 2009-01-30 | 2009-01-30 | 면역활성이 증진된 구멍갈파래 추출물의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090007332A KR101097799B1 (ko) | 2009-01-30 | 2009-01-30 | 면역활성이 증진된 구멍갈파래 추출물의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100088251A true KR20100088251A (ko) | 2010-08-09 |
KR101097799B1 KR101097799B1 (ko) | 2011-12-23 |
Family
ID=42754496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090007332A KR101097799B1 (ko) | 2009-01-30 | 2009-01-30 | 면역활성이 증진된 구멍갈파래 추출물의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101097799B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015071497A1 (fr) * | 2013-11-18 | 2015-05-21 | Amadeite | Extrait d'algues pour son utilisation en tant qu'agent immunomodulateur |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102249253B1 (ko) | 2019-10-11 | 2021-05-07 | 제천한약영농조합법인 | 오자, 오가피, 야관문 및 계피를 이용한 리큐르주의 제조방법 |
KR102428520B1 (ko) | 2020-06-26 | 2022-08-03 | 제천한약영농조합법인 | 홍삼농축액, 당귀추출물, 클로렐라 및 소엽추출물을 이용한 리큐르주의 제조방법 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100908425B1 (ko) | 2008-08-12 | 2009-07-21 | 한국해양연구원 | 해조류를 이용한 바이오에탄올 제조용 고압 액화 추출물 및이의 제조방법 |
-
2009
- 2009-01-30 KR KR1020090007332A patent/KR101097799B1/ko active IP Right Grant
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015071497A1 (fr) * | 2013-11-18 | 2015-05-21 | Amadeite | Extrait d'algues pour son utilisation en tant qu'agent immunomodulateur |
FR3013222A1 (fr) * | 2013-11-18 | 2015-05-22 | Amadeite | Extrait d'algues pour son utilisation en tant qu'agent immunomodulateur |
JP2016539184A (ja) * | 2013-11-18 | 2016-12-15 | アマデイト | 免疫調節剤としての用いるための藻類抽出物 |
RU2687498C2 (ru) * | 2013-11-18 | 2019-05-14 | Амадет | Экстракт водорослей для использования в качестве иммуномодулирующего агента |
US10912805B2 (en) | 2013-11-18 | 2021-02-09 | Amadeite | Extract of algae for use as an immunomodulator agent |
Also Published As
Publication number | Publication date |
---|---|
KR101097799B1 (ko) | 2011-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5269160B2 (ja) | 生理活性液状組成物及びその製造方法 | |
Carvajal et al. | Bioactives of fruiting bodies and submerged culture mycelia of Agaricus brasiliensis (A. blazei) and their antioxidant properties | |
Kalyoncu et al. | Antimicrobial and antioxidant activities of mycelia of 10 wild mushroom species | |
US9512453B2 (en) | Method for preparing novel processed ginseng or an extract thereof, the usually minute ginsenoside content of which is increased | |
CN104473145A (zh) | 一种牛樟芝深层发酵复方制品及其制备方法 | |
CN109207544A (zh) | 一种小球藻抗氧化多肽的制备方法 | |
KR101097799B1 (ko) | 면역활성이 증진된 구멍갈파래 추출물의 제조방법 | |
CN104593441A (zh) | 一种从松茸中同时提取挥发油、多糖和氨基酸的方法 | |
KR20130011511A (ko) | 발효삼 식품 제조방법 | |
Hamza et al. | An insight into the nutritional and medicinal value of edible mushrooms: A natural treasury for human health | |
CN105368901A (zh) | 一种利用仿刺参加工液提取抗菌多肽的方法 | |
CN105368895A (zh) | 一种制备具有抗氧化活性鼎湖鳞伞菌胞内、胞外多糖的方法 | |
KR20150094176A (ko) | 특정 진세노사이드의 함량을 증진시킨 인삼 열매 추출물 | |
Zhao et al. | In vitro antioxidant and antitumor activities of polysaccharides extracted from the mycelia of liquid-cultured Flammulina velutipes | |
Oh et al. | Physiological activity of tofu fermented with mushroom mycelia | |
TWM590969U (zh) | 具有仿生物間質系統的芸香科植物發酵液微粒結構 | |
CN115778888A (zh) | 一种白及提取物的制备方法及其产品和应用 | |
KR20120053564A (ko) | 영지발효삼 음료 제조방법과 그 음료 | |
Zhang et al. | Antioxidative and immunomodulatory activities of the exopolysaccharides from submerged culture of hen of the woods or maitake culinary-medicinal mushroom, Grifola frondosa (Agaricomycetes) by addition of Rhizoma Gastrodiae extract and its main components | |
Shashidhar et al. | Antioxidant and cholesterol esterase inhibitory properties of supplementation with coconut water in submerged cultivation of the medicinal Chinese caterpillar mushroom, Ophiocordyceps sinensis CS1197 (Ascomycetes) | |
KR101045011B1 (ko) | 비타민나무를 이용한 발효 조성물을 제조하는 방법 | |
US11458180B2 (en) | Environmentally-friendly preparation method of composition containing anti-inflammatory active ingredients and use of composition | |
Wei et al. | Optimization of Polyphenol Extraction from Agaricus blazei Murrill and Determination of its Antioxidant Activities. | |
CN107029028A (zh) | 一种小叶金露梅提取物及制备方法及其抗肿瘤活性的应用 | |
KR102364062B1 (ko) | 활성산양삼을 함유하는 항염증 조성물 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20140912 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20151012 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20160927 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20180205 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20181030 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20191001 Year of fee payment: 9 |